print this page | email this page
Stanford’s Kuldev Singh, MD Elected to Chair the Glaucoma Research Foundation
San Francisco, CA – July 1, 2009 – Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service at the Stanford University School of Medicine, will serve as the new Board Chair of the Glaucoma Research Foundation. He was elected Chairman at the recent Board of Directors Annual Meeting. The Glaucoma Research Foundation (GRF) is America’s oldest national institution dedicated solely to preventing vision loss from glaucoma.
Prior to Dr. Singh, Deirdre Porter served as GRF’s Board Chair for three years. Ms. Porter is Executive Vice President and Portfolio Manager of Wentworth, Hauser and Violich, Inc in San Francisco.
Also serving as Officers on the Board of Directors for GRF’s fiscal year 2010 are Andrew Iwach, MD, Associate Clinical Professor of Ophthalmology at the University of California at San Francisco as Vice Chair, Michael L. Penn, Sr. as Secretary, and Fred H. Brinkmann as Board Treasurer.
About Kuldev Singh, MD
Dr. Singh received his MD and MPH degrees from the Johns Hopkins University School of Medicine. He has received Senior Achievement and Secretariat awards from the American Academy of Ophthalmology and the Franklin G. Ebaugh Award from Stanford University where he has served on the faculty since 1992. Dr. Singh also currently serves on the Board of Directors for the American Glaucoma Society and is Executive Vice President of the World Glaucoma Association.
Dr. Singh joined the GRF Board of Directors in April 2007. He is Chairman of the Patient Education Committee and the GRF Council, a national leadership group of glaucoma specialists. Effective July 1, 2009, Dr. Singh will succeed Ms. Deirdre Porter of the San Francisco firm Wentworth, Hauser, and Violich, Inc. who has served the past three years as Board Chair for the Foundation.
“Kuldev has already brought many inventive ideas to GRF during his time serving on the Board of Directors, and we look forward to the leadership that his broad knowledge and experience in the field of glaucoma will bring to the Foundation,” said Thomas M. Brunner, GRF President and CEO.
About The Glaucoma Research Foundation
The Glaucoma Research Foundation is the nation’s largest non governmental funding agency dedicated solely to glaucoma research and education having raised over $45 million to support this mission. In addition to funding projects such as the Catalyst For a Cure Research Consortium and the Shaffer Grants for Innovative Glaucoma Research, GRF is also the “go to” source for education materials such as ‘Understanding and Living with Glaucoma’ a resource for patients newly diagnosed with the disease. The Foundation’s Newsletter, Gleams, reaches over 100,000 glaucoma patients, physicians, scientists and educators throughout the United States.